Procainamide INN (d; trade names Pronestyl, Procan, Procanbid) is a pharmaceutical antiarrhythmic agent used for the medical treatment of cardiac arrhythmias, classified by the Vaughan Williams classification system as class Ia. ==History== Procainamide was approved by the US FDA on June 2, 1950, under the brand name Pronestyl. It was launched by ...
Found on
http://en.wikipedia.org/wiki/Procainamide
(from the article `drug`) Quinidine, procainamide, lidocaine, and phenytoin exert their antiarrhythmic effects by reducing electrical excitability. Quinidine and procainamide ... ...The signs and symptoms resemble those of systemic lupus. The most common drugs that cause such an autoimmune response are hydralazine, which is ... [2 re...
Found on
http://www.britannica.com/eb/a-z/p/117
<chemical> A derivative of procaine with less CNS action. It is used in cardiac arrhythmias. ... It differs chemically from procaine by containing the amide group (CONH) instead of the ester group (COO). It depresses the irritability of the cardiac muscle, having a quinidine-like action upon the heart, and is used in ventricular arrhythmias.
Found on
http://www.encyclo.co.uk/local/20973
(pro-kān´ә-mīd) a cardiac depressant used as the hydrochloride salt in the treatment of cardiac arrhythmias, administered orally, intramuscularly, or intravenously.
Found on
http://www.encyclo.co.uk/local/21001
Antiarrhythmic used in treatment of ventricular arrhythmias.
Found on
https://www.encyclo.co.uk/local/22445
No exact match found.
